Understanding how diet affects brain health and Alzheimer's disease in different groups

Dietary factors, neuroinflammation, plasma neurodegenerative biomarkers and Alzheimer’s disease in diverse cohorts

NIH-funded research Rush University Medical Center · NIH-11181636

This project explores how healthy eating habits might protect the brain from Alzheimer's disease by looking at inflammation and specific markers in the blood, especially in diverse communities.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11181636 on NIH RePORTER

What this research studies

We know that healthy diets are linked to slower memory decline and less Alzheimer's disease changes in the brain, but we don't fully understand why. This project aims to uncover the hidden ways that certain foods, nutrients, and plant compounds called flavonoids might reduce brain inflammation and oxidative stress, which are key factors in Alzheimer's. We will also look at how diet relates to new blood tests that can show signs of Alzheimer's disease and brain cell damage. Our goal is to learn more about these connections in a variety of people, including those from underrepresented groups, to help develop better prevention strategies.

Who could benefit from this research

Good fit: This research is relevant for individuals interested in how diet impacts brain health, particularly those concerned about Alzheimer's disease and from diverse backgrounds.

Not a fit: Patients seeking immediate treatment for active Alzheimer's disease may not directly benefit from this foundational research.

Why it matters

Potential benefit: If successful, this work could help us understand how specific dietary choices can protect brain health and reduce the risk of Alzheimer's disease, leading to new prevention strategies.

How similar studies have performed: Animal studies have shown brain health benefits from dietary factors through inflammatory and oxidative pathways, suggesting a promising direction for human research.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.